Viasat Confirms Successful Launch of ViaSat-3 F2 Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
BOSTON, Feb. 04, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Immunocore Announces Pricing of Upsized Initial Public Offering
PRESS RELEASE Immunocore Announces Pricing of Upsized Initial Public Offering OXFORDSHIRE, England & CONSHOHOCKEN, Penn….
Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct Offering
LAKE FOREST, Ill., Feb. 05, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
FOSTER CITY, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Pharvaris Announces Pricing of Upsized Initial Public Offering
ZUG, Switzerland, Feb. 04, 2021 (GLOBE NEWSWIRE) — Pharvaris N.V. (“Pharvaris”), a clinical-stage biopharmaceutical company…
Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled…
Zealand Pharma to Host R&D Day on March 5, 2021
Company announcement – No. 5 / 2021 Zealand Pharma to Host R&D Day on March…
Evaxion Biotech Announces Pricing of Initial Public Offering
COPENHAGEN, Denmark, Feb. 04, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (“Evaxion”), a clinical-stage biotechnology…
Berkeley Lights Announces CFO Transition and C-Level Additions
Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO,…
Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Rolling reviews have commenced by FDA, MHRA, EMA and Health Canada GAITHERSBURG, Md., Feb. 04,…
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus
Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence…
Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2021
Monthly information related to total number of voting rights and shares composing the…
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) will release…
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive…
AGTC Executives Awarded First Place in the BioProcess International Reader’s Choice Awards, Cell & Gene Therapies Category
Article reflects Company’s leadership and innovation in scalable, reproducible manufacture of adeno-associated virus (AAV)-based gene…
EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock
WATERTOWN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced…
Outlook Therapeutics’ Recent Financing Secures Funding to Support ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Through Planned BLA Submission
Overallotment option on recent public offering partially exercised by underwriter Closed concurrent private placement for…
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301
Milestone Marks Advance for Oral Mucosal Immunotherapy for Peanut Allergies NEW YORK, Feb. 04, 2021…